These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 29992976)
41. Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension. Li Q; Barrett A; Vijayakrishnan B; Tiberghien A; Beard R; Rickert KW; Allen KL; Christie RJ; Marelli M; Harper J; Howard P; Wu H; Dall'Acqua WF; Tsui P; Gao C; Borrok MJ Bioconjug Chem; 2019 Apr; 30(4):1232-1243. PubMed ID: 30912649 [TBL] [Abstract][Full Text] [Related]
42. Sequence-selective recognition of duplex DNA through covalent interstrand cross-linking: kinetic and molecular modeling studies with pyrrolobenzodiazepine dimers. Smellie M; Bose DS; Thompson AS; Jenkins TC; Hartley JA; Thurston DE Biochemistry; 2003 Jul; 42(27):8232-9. PubMed ID: 12846572 [TBL] [Abstract][Full Text] [Related]
43. Antibody Drug Conjugates Differentiate Uptake and DNA Alkylation of Pyrrolobenzodiazepines in Tumors from Organs of Xenograft Mice. Ma Y; Khojasteh SC; Hop CE; Erickson HK; Polson A; Pillow TH; Yu SF; Wang H; Dragovich PS; Zhang D Drug Metab Dispos; 2016 Dec; 44(12):1958-1962. PubMed ID: 27683653 [TBL] [Abstract][Full Text] [Related]
44. An asymmetric C8/C8'-tripyrrole-linked sequence-selective pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimer DNA interstrand cross-linking agent spanning 11 DNA base pairs. Tiberghien AC; Evans DA; Kiakos K; Martin CR; Hartley JA; Thurston DE; Howard PW Bioorg Med Chem Lett; 2008 Mar; 18(6):2073-7. PubMed ID: 18272367 [TBL] [Abstract][Full Text] [Related]
45. Optimization of the antitumor activity of sequence-specific pyrrolobenzodiazepine derivatives based on their affinity for ABC transporters. Kaliszczak M; Antonow D; Patel KI; Howard P; Jodrell DI; Thurston DE; Guichard SM AAPS J; 2010 Dec; 12(4):617-27. PubMed ID: 20703960 [TBL] [Abstract][Full Text] [Related]
46. Fractionated Dosing Improves Preclinical Therapeutic Index of Pyrrolobenzodiazepine-Containing Antibody Drug Conjugates. Hinrichs MJM; Ryan PM; Zheng B; Afif-Rider S; Yu XQ; Gunsior M; Zhong H; Harper J; Bezabeh B; Vashisht K; Rebelatto M; Reed M; Ryan PC; Breen S; Patel N; Chen C; Masterson L; Tiberghien A; Howard PW; Dimasi N; Dixit R Clin Cancer Res; 2017 Oct; 23(19):5858-5868. PubMed ID: 28630216 [No Abstract] [Full Text] [Related]
47. Design, synthesis, and evaluation of mixed imine-amine pyrrolobenzodiazepine dimers with efficient DNA binding affinity and potent cytotoxicity. Kamal A; Ramesh G; Srinivas O; Ramulu P; Laxman N; Rehana T; Deepak M; Achary MS; Nagarajaram HA Bioorg Med Chem; 2004 Oct; 12(20):5427-36. PubMed ID: 15388169 [TBL] [Abstract][Full Text] [Related]
48. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores. Tercel M; Stribbling SM; Sheppard H; Siim BG; Wu K; Pullen SM; Botting KJ; Wilson WR; Denny WA J Med Chem; 2003 May; 46(11):2132-51. PubMed ID: 12747786 [TBL] [Abstract][Full Text] [Related]
49. Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies. Rios-Doria J; Harper J; Rothstein R; Wetzel L; Chesebrough J; Marrero A; Chen C; Strout P; Mulgrew K; McGlinchey K; Fleming R; Bezabeh B; Meekin J; Stewart D; Kennedy M; Martin P; Buchanan A; Dimasi N; Michelotti E; Hollingsworth R Cancer Res; 2017 May; 77(10):2686-2698. PubMed ID: 28283653 [TBL] [Abstract][Full Text] [Related]
50. Cellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross-linking agents. Smellie M; Kelland LR; Thurston DE; Souhami RL; Hartley JA Br J Cancer; 1994 Jul; 70(1):48-53. PubMed ID: 8018540 [TBL] [Abstract][Full Text] [Related]
51. Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs. Cipolla L; Araújo AC; Airoldi C; Bini D Anticancer Agents Med Chem; 2009 Jan; 9(1):1-31. PubMed ID: 19149479 [TBL] [Abstract][Full Text] [Related]
52. From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs). Mantaj J; Jackson PJ; Rahman KM; Thurston DE Angew Chem Int Ed Engl; 2017 Jan; 56(2):462-488. PubMed ID: 27862776 [TBL] [Abstract][Full Text] [Related]
53. Chemical Structure and Concentration of Intratumor Catabolites Determine Efficacy of Antibody Drug Conjugates. Zhang D; Yu SF; Ma Y; Xu K; Dragovich PS; Pillow TH; Liu L; Del Rosario G; He J; Pei Z; Sadowsky JD; Erickson HK; Hop CE; Khojasteh SC Drug Metab Dispos; 2016 Sep; 44(9):1517-23. PubMed ID: 27417182 [TBL] [Abstract][Full Text] [Related]
54. Activity of the DNA minor groove cross-linking agent SG2000 (SJG-136) against canine tumours. Mellinas-Gomez M; Spanswick VJ; Paredes-Moscosso SR; Robson M; Pedley RB; Thurston DE; Baines SJ; Stell A; Hartley JA BMC Vet Res; 2015 Aug; 11():215. PubMed ID: 26282406 [TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and in vitro cytotoxicity studies of novel pyrrolo[2,1-c][1,4]benzodiazepine (PBD)--polymade conjugates and 2,2'-PBD dimers. Reddy BS; Damayanthi Y; Reddy BS; Lown JW Anticancer Drug Des; 2000 Jun; 15(3):225-38. PubMed ID: 11049090 [TBL] [Abstract][Full Text] [Related]
56. Interactions of pyrrolobenzodiazepine dimers and duplex DNA from methicillin-resistant Staphylococcus aureus. Hadjivassileva T; Stapleton PD; Thurston DE; Taylor PW Int J Antimicrob Agents; 2007 Jun; 29(6):672-8. PubMed ID: 17350809 [TBL] [Abstract][Full Text] [Related]
57. Recent developments in novel pyrrolo[2,1-c][1,4]benzodiazepine conjugates: synthesis and biological evaluation. Kumar R; Lown JW Mini Rev Med Chem; 2003 Jun; 3(4):323-39. PubMed ID: 12678826 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and in vitro evaluation of SG3227, a pyrrolobenzodiazepine dimer antibody-drug conjugate payload based on sibiromycin. Kemp GC; Tiberghien AC; Patel NV; D'Hooge F; Nilapwar SM; Adams LR; Corbett S; Williams DG; Hartley JA; Howard PW Bioorg Med Chem Lett; 2017 Mar; 27(5):1154-1158. PubMed ID: 28188066 [TBL] [Abstract][Full Text] [Related]